Chemo tied to gut microbiome changes and associated cognitive decline
Jul 23, 2024
The findings were independent of chemotherapy-induced inflammation.
FDA approves another blood test for colon cancer screening
Jul 29, 2024
Currently, colonoscopy is the gold standard test for colon cancer, but adherence to it is low because it is invasive and preparation for the test is daunting.
Endocrine Society, June 1-4
Jun 20, 2024
The conference highlighted recent advances in the diagnosis and management of obesity, endocrine disorders, diabetes, and growth hormone and thyroid diseases.
Heart, diabetes, cancer drugs on list for Medicare price negotiations, White House says
Aug 29, 2023
Enrollees in the Medicare prescription drug program paid a total of $3.4 billion in out-of-pocket costs in 2022 for the 10 initial drugs chosen for price negotiations.
New CDC profile shares demographics of assisted living residents
By
Kimberly Bonvissuto
Sep 22, 2021
Bathing, walking and dressing are the most common activities of daily living that residents of assisted living or similar residential communities need help with, according to a new data brief from the...
Where dementia is most prevalent
By
Lois A. Bowers
Feb 03, 2016
A new tool from the federal government provides county- and state-level prevalence data for Alzheimer’s/dementia and 15 other chronic conditions.
Legislation to boost home infusion receives kudos
By
Diane Eastabrook
Aug 11, 2021
The National Home Infusion Association (NHIA) is praising bipartisan legislation that would ensure that Medicare patients continue gaining access to home infusion therapies that require the use of an infusion...
In-home chemo infusion poses numerous health risks, groups insist
By
John O'Connor
Sep 24, 2020
Although many healthcare professionals see a bright future for telehealth and expanded care in home care settings, oncology groups are drawing the line at chemotherapy infusions.
Decline seen in patients undergoing surgery for colon, rectal cancer in 2020
Apr 11, 2024
Patients undergoing surgery in 2020 versus 2019 had a more advanced clinical and pathological tumor stage.
Sentinel node biopsy questioned for some older women with breast cancer
Apr 13, 2022
Grade 3 tumor and negative progesterone receptor status was strongly associated with a high genetic recurrence score.